[go: up one dir, main page]

IL208199A0 - Methods and compositions for deterring abuse of orlly administered pharmaceutical products - Google Patents

Methods and compositions for deterring abuse of orlly administered pharmaceutical products

Info

Publication number
IL208199A0
IL208199A0 IL208199A IL20819910A IL208199A0 IL 208199 A0 IL208199 A0 IL 208199A0 IL 208199 A IL208199 A IL 208199A IL 20819910 A IL20819910 A IL 20819910A IL 208199 A0 IL208199 A0 IL 208199A0
Authority
IL
Israel
Prior art keywords
orlly
compositions
methods
pharmaceutical products
administered pharmaceutical
Prior art date
Application number
IL208199A
Original Assignee
Acura Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/136,636 external-priority patent/US20060177380A1/en
Application filed by Acura Pharmaceuticals Inc filed Critical Acura Pharmaceuticals Inc
Publication of IL208199A0 publication Critical patent/IL208199A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL208199A 2004-11-24 2010-09-16 Methods and compositions for deterring abuse of orlly administered pharmaceutical products IL208199A0 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US63099104P 2004-11-24 2004-11-24
US63983104P 2004-12-28 2004-12-28
US64363705P 2005-01-13 2005-01-13
US66397305P 2005-03-22 2005-03-22
US11/136,636 US20060177380A1 (en) 2004-11-24 2005-05-24 Methods and compositions for deterring abuse of orally administered pharmaceutical products
US69389805P 2005-06-24 2005-06-24
PCT/US2005/042808 WO2006058249A2 (en) 2004-11-24 2005-11-23 Methods and compositions for deterring abuse of orally administered pharmaceutical products

Publications (1)

Publication Number Publication Date
IL208199A0 true IL208199A0 (en) 2010-12-30

Family

ID=36461130

Family Applications (2)

Application Number Title Priority Date Filing Date
IL183362A IL183362A (en) 2004-11-24 2007-05-21 Compositions for deterring abuse of orally administered pharmaceutical products
IL208199A IL208199A0 (en) 2004-11-24 2010-09-16 Methods and compositions for deterring abuse of orlly administered pharmaceutical products

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL183362A IL183362A (en) 2004-11-24 2007-05-21 Compositions for deterring abuse of orally administered pharmaceutical products

Country Status (1)

Country Link
IL (2) IL183362A (en)

Also Published As

Publication number Publication date
IL183362A (en) 2014-09-30
IL183362A0 (en) 2007-09-20

Similar Documents

Publication Publication Date Title
EP1817011A4 (en) Methods and compositions for deterring abuse of orally administered pharmaceutical products
EP1993519A4 (en) Methods and compositions for deterring abuse of orally administered pharmaceutical products
GB0315861D0 (en) Improvements in pharmaceutical compositions for treatment of drug abuse
IL183105A0 (en) 4-arylamino pyridone derivatives and pharmaceutical compositions containing them
IL180517A0 (en) Novel statin pharmaceutical compositions and related methods of treatment
IL220480A0 (en) 1-benzyl-pyrimidine-2,4-dione derivatives as dipeptidyl peptidase inhibitors , preparation method thereof, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
IL174683A0 (en) Pharmaceutical compositions for prevention of overdose or abuse
IL193762A (en) Compounds useful in inhibiting dgat1-related disorders, pharmaceutical compositions comprising them and use thereof in preparation of medicaments
EP2099449A4 (en) Pharmaceutical composition for the treatment and prevention of diseases involving impotence
IL182863A0 (en) Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof
SI1765293T1 (en) Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
IL197275A0 (en) Pharmaceutical compositions of clonazepam and methods of use thereof
IL176108A0 (en) Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
PL1794174T3 (en) Methods and compositions for inhibition of innate immune responses and autoimmunity
EP1804832A4 (en) Methods and compositions for needleless delivery of macromolecules
EP1786609A4 (en) Separation of plastic and elastomers for food and pharmaceutical products
IL183986A0 (en) Pharmaceutical compounds and compositions
ZA200900423B (en) Methods and medicaments for administration of ibuprofen
AP2008004447A0 (en) Orally absorbed pharmaceutical formulation and method of administration
IL179627A0 (en) Particulate-stabilized injectable pharmaceutical compositions of posaconasole
GB0608398D0 (en) Pharmaceutical composition and method of using same
IL178067A0 (en) Pharmaceutical dosage forms and compositions
IL208199A0 (en) Methods and compositions for deterring abuse of orlly administered pharmaceutical products
EP1855647A4 (en) Delayed release pharmaceutical oral dosage form and method of making same
ZA200701578B (en) Combination anticancer therapy and pharmaceutical compositions therefore